Nasdaq · CIK 0001799011
LUCD Lucid Diagnostics Inc.
Insider trading from SEC Form 4. Last filing May 23, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
4
with a Form 4 at this company
Signals
Open-market buys and sells at Lucid Diagnostics Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | Dennis Matheis director buy | $458k 350,000 shares | +162% | - | |
| 40Moderate | Dennis Matheis director buy | $458k 350,000 shares | - | - |
Transactions
The last 9 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2025 | Dennis Matheis director | POpen-market purchase Common Stock | +187,098 | $1.30 | $242k | 402,541 | May 23, 2025 |
| May 21, 2025 | Dennis Matheis director | POpen-market purchase Common Stock | +129,684 | $1.32 | $172k | 532,225 | May 23, 2025 |
| May 22, 2025 | Dennis Matheis director | POpen-market purchase Common Stock | +33,218 | $1.32 | $44k | 565,443 | May 23, 2025 |
| May 20, 2025 | Dennis Matheis director | POpen-market purchase Common Stock | +187,098 | $1.30 | $242k | 187,098 | May 22, 2025 |
| May 21, 2025 | Dennis Matheis director | POpen-market purchase Common Stock | +129,684 | $1.32 | $172k | 316,782 | May 22, 2025 |
| May 22, 2025 | Dennis Matheis director | POpen-market purchase Common Stock | +33,218 | $1.32 | $44k | 350,000 | May 22, 2025 |
| Feb 20, 2025 | Lishan Aklog Chief Executive Officer | AGrant or award Common Stock | +300,000 | $0.00 | $0 | 1,466,627 | Feb 21, 2025 |
| Feb 20, 2025 | James L Cox director | AGrant or award Common Stock | +112,800 | $0.00 | $0 | 282,120 | Feb 21, 2025 |
| Feb 20, 2025 | Michael Adam Gordon General Counsel and Secretary | AGrant or award Common stock | +300,000 | $0.00 | $0 | 700,000 | Feb 21, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Lishan AklogChief Executive Officer
- James L Coxdirector
- Michael Adam GordonGeneral Counsel and Secretary
- Dennis Matheisdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.